ATP5A1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.2965000052474E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.182400E-04 |
Normal-vs-Stage2 |
6.448000E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.692400E-02 |
Stage1-vs-Stage2 |
9.941800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.734800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.232000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.21560000241072E-08 |
Normal-vs-AfricanAmerican |
4.150800E-01 |
Normal-vs-Asian |
2.746000E-01 |
Caucasian-vs-AfricanAmerican |
5.998200E-01 |
Caucasian-vs-Asian |
2.656000E-01 |
AfricanAmerican-vs-Asian |
2.771400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.350100E-04 |
Normal-vs-Female |
1.62542999999626E-05 |
Male-vs-Female |
1.283550E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.256310E-02 |
Normal-vs-Extreme_Weight |
1.60166999999545E-05 |
Normal-vs-Obese |
4.602200E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.160800E-01 |
Normal_Weight-vs-Obese |
6.154600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.150000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.695400E-01 |
Normal-vs-Age(41-60Yrs) |
8.998800E-04 |
Normal-vs-Age(61-80Yrs) |
9.56439999999503E-05 |
Normal-vs-Age(81-100Yrs) |
3.489200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.433200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.034500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.354000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.948500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.993000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.365200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.179600E-01 |
Normal-vs-Grade 3 |
8.061600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.079600E-01 |
Grade 2-vs-Grade 4 |
9.179600E-01 |
Grade 3-vs-Grade 4 |
8.061600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.66412000000005E-05 |
Normal-vs-N1 |
1.479410E-01 |
N0-vs-N1 |
8.541800E-01 |
|
|